by Trinity College Dublin Graphical abstract. Credit: Journal of Clinical Investigation (2022). DOI: 10.1172/JCI162581 A review of the COVID-19 vaccine trials indicate that adenovirus vectored vaccines may have non-specific protective effects resulting in significantly reduced all-cause mortality and non-COVID deaths, compared with mRNA based COVID-19 vaccines. The mechanism behind this observation is unknown. New Trinity research has discovered that...
Tag: <span>AstraZeneca vaccine</span>
Research indicates wider benefit to AstraZeneca vaccine
by Trinity College Dublin Graphical abstract. Credit: Journal of Clinical Investigation (2022). DOI: 10.1172/JCI162581 A review of the COVID-19 vaccine trials indicate that adenovirus vectored vaccines may have non-specific protective effects resulting in significantly reduced all-cause mortality and non-COVID deaths, compared with mRNA based COVID-19 vaccines. The mechanism behind this observation is unknown. New Trinity research has discovered that...
Researchers identify rise in Guillain-Barré syndrome following AstraZeneca vaccine
by University College London In typical GBS, virus particles stimulate the immune system to produce antibodies that detect both viral surface proteins, but also proteins on the surface of peripheral nerves that cause “auto-immune” destruction. Credit: Dr. Stephen Keddie, UCL A correlation between a first dose of the AstraZeneca vaccine and a small but significant...
AstraZeneca vaccine and Guillain-Barré syndrome: There’s minimal cause for concern
by Nathan Bartlett, The Conversation In people with Guillain-Barré syndrome, the immune system attacks healthy nerve cells. Credit: Shutterstock The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca COVID vaccine. This is an autoimmune disorder, which causes muscle weakness, numbness and tingling. It can be life threatening if it involves...
Scientists find clues to why AstraZeneca’s vaccine may cause clots
by Dennis Thompson Healthday Reporter (HealthDay)—Doctors might have figured out why AstraZeneca’s COVID-19 vaccine may cause life-threatening blood clots in very rare cases. The discovery, made in a pair of reports published online Friday in the New England Journal of Medicine, could be key to the global rollout of the AstraZeneca vaccine, helping develop effective treatments...